Current status of nanomaterial-based treatment for hepatocellular carcinoma
Cancer continues to be the leading cause of death worldwide. Hepatocellular carcinoma (HCC), a prominent form of liver cancer, is the second leading cause of cancer-related deaths, thanks to the lack of efficient diagnostic tools and consequently late diagnosis and to the scarce of available suitabl...
Main Authors: | Badriya Baig, Sulafa Abdel Halim, Aaminah Farrukh, Yaser Greish, Amr Amin |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2019-08-01
|
Series: | Biomedicine & Pharmacotherapy |
Subjects: | |
Online Access: | http://www.sciencedirect.com/science/article/pii/S0753332218388176 |
Similar Items
-
Current Status of Gene Therapy in Hepatocellular Carcinoma
by: Saranya Chidambaranathan Reghupaty, et al.
Published: (2019-08-01) -
Emerging and Innovative Theranostic Approaches for Mesoporous Silica Nanoparticles in Hepatocellular Carcinoma: Current Status and Advances
by: Yaoye Tao, et al.
Published: (2020-03-01) -
Nanomaterials for cancer therapies
by: Zhou Qing, et al.
Published: (2017-10-01) -
Current applications and future prospects of nanomaterials in tumor therapy
by: Huang Y, et al.
Published: (2017-03-01) -
Metallic Nanomaterials for Sensitivity Enhancement of Fluorescence Detection
by: Fang Xie, et al.
Published: (2007-02-01)